| Jun 23, 2014
| 1:30 PM
Abbott Laboratories said Monday it has agreed to acquire a Russian pharmaceutical manufacturer for between $395 million and $495 million in cash plus the assumption of about $136 million in debt. The Lake County-based medical products company will...
| Jun 20, 2014
| 2:59 PM
Irish pharmaceutical company Shire Plc said Friday it had rejected a $46.3 billion takeover offer from North Chicago-based AbbVie Inc., thwarting, at least for now, the company’s attempt to tap into the London-listed company’s low tax rate....
| Jun 27, 2014
| 6:14 PM
After more than a decade of work and nearly $1 billion of his personal fortune, Los Angeles inventor Alfred Mann's quest to develop an inhalable form of insulin for people with diabetes won approval Friday from U.S. regulators.
His company, MannKind...
| Jun 25, 2014
| 5:17 PM
Seven U.S. senators have asked the Justice Department and Federal Trade Commission to review the proposed acquisition of Botox maker Allergan Inc. by a Canadian company, saying the deal could increase consumer pricing and curtail the development of new...
| Jun 4, 2014
| 9:53 AM
The Illinois Attorney General on Wednesday announced the state was part of a $105 million settlement with GlaxoSmithKline LLC to resolve allegations that the company unlawfully promoted its asthma drug Advair and antidepressants Paxil and Wellbutrin....
| Jun 25, 2014
| 7:15 AM
AbbVie Inc. on Wednesday took its fight for control of the Irish drugmaker Shire Plc directly to shareholders, calling for immediate talks for a transaction it views as "highly executable."
The North Chicago-based pharmaceutical firm, know for its...
| Jun 10, 2014
| 3:14 PM
"Doctor shopping" for illicit prescription drugs by Virginia residents showed a 73 percent decline from 2012 to 2013, according to data released this week by the Virginia Prescription Monitoring Program.
The online program allows registered users...
| Jun 30, 2014
| 7:04 PM
MannKind Corp., the Valencia company that last week won approval to market an inhalable form of insulin to people with diabetes, saw its shares climb 10% on Monday.
The Food and Drug Administration announced Friday that it had approved MannKind's drug,...
| Jul 17, 2014
| 6:55 AM
AbbVie Inc. is buying Shire for nearly $55 billion, the largest deal in a year filled with merger and acquisition activity, and the latest example of companies taking foreign addresses to cut taxes.
The deal will allow North Chicago-based pharmaceutical...
| May 7, 2014
| 2:30 AM
It seems the "anti-vaccine" movement is still alive and well and has become a hot topic on Twitter and Facebook again. Unfortunately, much of what I've read on these sites seems to be inaccurate and based on a lot of emotion and very little science....
| Apr 3, 2014
| 4:30 PM
DEAR MAYO CLINIC: I'm a 52-year-old man. I recently had blood work done that showed my testosterone levels are slightly low, falling just below the "normal" range. Should I talk to my doctor about getting treatment even if I don't have any symptoms?...